Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $76000.0.

  • Ocular Therapeutix's Change in Inventory fell 8803.15% to $76000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $524000.0, marking a year-over-year decrease of 2870.75%. This contributed to the annual value of $524000.0 for FY2025, which is 2870.75% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Change in Inventory of $76000.0 as of Q4 2025, which was down 8803.15% from $449000.0 recorded in Q3 2025.
  • Ocular Therapeutix's Change in Inventory's 5-year high stood at $635000.0 during Q4 2024, with a 5-year trough of -$230000.0 in Q2 2025.
  • For the 5-year period, Ocular Therapeutix's Change in Inventory averaged around $118150.0, with its median value being $64500.0 (2023).
  • As far as peak fluctuations go, Ocular Therapeutix's Change in Inventory skyrocketed by 143214.29% in 2022, and later tumbled by 75185.19% in 2025.
  • Ocular Therapeutix's Change in Inventory (Quarter) stood at $28000.0 in 2021, then skyrocketed by 1432.14% to $429000.0 in 2022, then tumbled by 88.81% to $48000.0 in 2023, then soared by 1222.92% to $635000.0 in 2024, then plummeted by 88.03% to $76000.0 in 2025.
  • Its Change in Inventory stands at $76000.0 for Q4 2025, versus $449000.0 for Q3 2025 and -$230000.0 for Q2 2025.